Read + Share
Cao J, Chan WC, Chow MSS. Use of conditional reprogramming cell, patient derived xenograft and organoid for
drug screening for individualized prostate cancer therapy: Current and future
perspectives (Review). Int J Oncol 2022;60.
PMID: 35322860
|
 |
|
